Sumitomo Pharma America, Inc.
Clinical trials sponsored by Sumitomo Pharma America, Inc., explained in plain language.
-
New pill hopes to shrink spleens in Hard-to-Treat bone marrow cancer
Disease control Recruiting nowThis study tests an experimental pill called nuvisertib in adults with myelofibrosis, a serious bone marrow disorder. The goal is to see if the drug is safe and can reduce spleen enlargement and other symptoms. Participants must have intermediate or high-risk disease and have alr…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Stem cell sheets injected into the eye: a new hope for retinitis pigmentosa?
Disease control Recruiting nowThis study tests the safety of a single injection of lab-grown retinal sheets (made from stem cells) into one eye of adults with retinitis pigmentosa, a genetic condition that causes progressive vision loss. Twelve participants will be split into three groups based on their curre…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC